The SHH/Gli axis regulates CD90‐mediated liver cancer stem cell function by activating the IL6/JAK2 pathway

The cell surface antigen CD90 has recently been established as a promising marker for liver cancer stem cells. This study aimed to investigate potential implications of SHH/Gli signalling in CD90+ liver cancer stem cells. Correlation of the expression of SHH signalling components and CD90 in liver c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ketao, Che, Siyao, Pan, Chuzhi, Su, Zheng, Zheng, Shangyou, Yang, Shanglin, Zhang, Huayao, Li, Wenda, Wang, Weidong, Liu, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010714/
https://www.ncbi.nlm.nih.gov/pubmed/29722127
http://dx.doi.org/10.1111/jcmm.13651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010714/
https://www.ncbi.nlm.nih.gov/pubmed/29722127
http://dx.doi.org/10.1111/jcmm.13651

Ejemplares similares